VOTRIENT identity
The active ingredient recorded for this profile is Pazopanib. Confirm the prescribed brand or ingredient before comparing packages.
Specialty Care medication reference
VOTRIENT price reference.
VOTRIENT (Pazopanib) has 18 European package references in this catalog. The listed range runs from 200 mg film-coated tablets · 30 tablets at €2,648.62 to 400 mg film-coated tablets · 60 tablets at €7,262.78. 1 package reference also includes recorded U.S. cash-price context ($13,451.49); compare only like-for-like strength, form and quantity. Figures are informational, not a quote or supply guarantee.
Estimated medicine cost range€2,648.62 – €7,262.78
Source-supported U.S. cash context$13,451.49
Estimated price differenceup to €6,304.36
Last recorded source review
Reference profile
Clear information.
Case-specific review.
The listed range runs from 200 mg film-coated tablets · 30 tablets at €2,648.62 to 400 mg film-coated tablets · 60 tablets at €7,262.78. These figures are catalog references, not an offer to sell or a guarantee of supply. The correct product, package, destination, licensed provider and importer must be reviewed for each request.
Package-level price scope
The listed range runs from 200 mg film-coated tablets · 30 tablets at €2,648.62 to 400 mg film-coated tablets · 60 tablets at €7,262.78. Strength, dosage form and quantity can materially change a like-for-like comparison.
Comparison evidence
1 package reference also includes recorded U.S. cash-price context ($13,451.49); compare only like-for-like strength, form and quantity.
Package references
VOTRIENT listed formats
European figures are dated estimated medicine cost references. U.S. cash context appears only where the catalog retains source provenance; compare the exact strength, form and quantity.
18 of 18 package references shown
No package references match that search. Try a shorter strength, dosage form, supplier or PZN.
| Package reference | Estimated medicine cost reference | Comparable U.S. cash reference | Estimated difference | Source notes | Select |
|---|---|---|---|---|---|
| 200 mg film-coated tablets · 30 tablets NOVARTIS Pharma GmbH · PZN 06431764 | €2,648.62 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 400 mg film-coated tablets · 30 tablets Orifarm GmbH · PZN 07574023 | €3,627.99 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 30 tablets Abacus Medicine A/S · PZN 11182636 | €3,647.57 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 30 tablets axicorp Pharma B.V. · PZN 01332655 | €3,709.56 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 30 tablets CC Pharma GmbH · PZN 09759241 | €3,735.38 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 30 tablets kohlpharma GmbH · PZN 14354405 | €3,798.30 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 30 tablets NOVARTIS Pharma GmbH · PZN 06431787 | €3,957.54 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 200 mg film-coated tablets · 90 tablets Abacus Medicine A/S · PZN 12452517 | €4,928.60 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 200 mg film-coated tablets · 90 tablets Orifarm GmbH · PZN 07574017 | €4,928.63 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 200 mg film-coated tablets · 90 tablets axicorp Pharma B.V. · PZN 10203661 | €5,098.86 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 200 mg film-coated tablets · 90 tablets NOVARTIS Pharma GmbH · PZN 06431770 | €5,464.15 | $13,451.49 | €6,304.36 | Imported legacy U.S. cash comparison; source package figure $17935.31; external source URL not recorded in the source workbook Recorded review: | Request this package |
| 400 mg film-coated tablets · 60 tablets Orifarm GmbH · PZN 07574046 | €5,861.09 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 60 tablets Aaragon Pharma s.r.o. · PZN 19093837 | €5,861.09 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 60 tablets PARANOVA PACK A/S · PZN 14143789 | €6,350.56 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 60 tablets Abacus Medicine A/S · PZN 10319814 | €6,393.20 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 60 tablets EurimPharm Arzneimittel GmbH · PZN 06140819 | €6,463.20 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
| 400 mg film-coated tablets · 60 tablets NOVARTIS Pharma GmbH · PZN 06431793 | €7,070.76 | Not listed | Case-specific comparison | Dated catalog record; current price and availability require review. Recorded review: | Request this package |
| 400 mg film-coated tablets · 60 tablets kohlpharma GmbH · PZN 14354411 | €7,262.78 | Not listed | Case-specific comparison | Dated European EUR source record; current price and availability require review. Recorded review: European source record ↗ | Request this package |
Data scopeReference information, not a quote
Displayed amounts are dated catalog references and may not include every tax, dispensing, shipping or route-specific cost. Exact identity, availability, prescription, destination and import route require separate review. U.S. amounts are shown only for records with retained comparison provenance. US Med Access does not dispense or sell medicines and provides no medical advice. Review the pricing and data methodology before comparing packages.
How the references are preparedSources and editorial responsibility
Where this VOTRIENT reference comes from
US Med Access publishes this page as an independent reference-information provider. Package records are retained with their available source notes and review dates; missing provenance is stated rather than inferred.
- Publisher and author
- US Med Access editorial team
- Recorded source review
- Reference scope
- 18 active European package records with supported U.S. cash-price context where listed
01
European package source recordEuropean reference · medipreis.de
↗
02
European package source recordEuropean reference · medipreis.de
↗
03
European package source recordEuropean reference · medipreis.de
↗
04
European package source recordEuropean reference · medipreis.de
↗
05
European package source recordEuropean reference · medipreis.de
↗
06
European package source recordEuropean reference · medipreis.de
↗
07
European package source recordEuropean reference · medipreis.de
↗
08
European package source recordEuropean reference · medipreis.de
↗
09
European package source recordEuropean reference · medipreis.de
↗
10
European package source recordEuropean reference · medipreis.de
↗
11
European package source recordEuropean reference · medipreis.de
↗
12
European package source recordEuropean reference · medipreis.de
↗
13
European package source recordEuropean reference · medipreis.de
↗
14
European package source recordEuropean reference · medipreis.de
↗
15
Drugs.com medicine price guideU.S. cash-price context · drugs.com
↗
16
US Med Access pricing and data methodologyMethodology · usmedaccess.com
↗
Frequently asked questions
VOTRIENT price and package questions
Direct answers based on the package records shown on this page. They do not replace medical, regulatory or dispensing advice.
01What is the listed VOTRIENT price in Europe?
The 18 listed European package references range from €2,648.62 – €7,262.78. The exact amount depends on strength, dosage form and pack quantity, so compare the specific package row rather than the range alone.
02How does the VOTRIENT European reference compare with U.S. cash prices?
Recorded U.S. cash-price context is $13,451.49 across 1 supported package reference. A comparison is meaningful only where strength, form and quantity are equivalent; source notes identify normalization or limitations.
03Are the listed VOTRIENT amounts a quote or sale offer?
No. They are informational catalog references. US Med Access is an independent sourcing consultant and does not sell or dispense medicines. Current availability, route, prescription and total cost require separate review.
04How do I request the correct VOTRIENT package?
Select the row that matches the prescribed strength, dosage form and quantity, then include the destination and request details. A package-level review is required before any next step.
Availability and logistics
Need a package-level review?
Start with the medication, package and destination. The sourcing team will assess the specific request without promising a supply, import or delivery outcome.